Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000328396 | SCV000340692 | pathogenic | not provided | 2016-03-30 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV001004314 | SCV001163195 | likely pathogenic | Peroxisome biogenesis disorder 1A (Zellweger); Peroxisome biogenesis disorder 1B | criteria provided, single submitter | clinical testing | ||
Gene |
RCV000328396 | SCV001168949 | pathogenic | not provided | 2018-11-08 | criteria provided, single submitter | clinical testing | The c.3303_3304dupAT variant in the PEX1 gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The c.3303_3304dupAT variant causes a frameshift starting with codon Cysteine 1102, changes this amino acid to a Tyrosine residue, and creates a premature Stop codon at position 4 of the new reading frame, denoted p.Cys1102TyrfsX4. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The c.3303_3304dupAT variant is not observed in large population cohorts (Lek et al., 2016). We interpret c.3303_3304dupAT as a pathogenic variant. |
Labcorp Genetics |
RCV001214049 | SCV001385712 | pathogenic | Zellweger spectrum disorders | 2023-12-11 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Cys1102Tyrfs*4) in the PEX1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PEX1 are known to be pathogenic (PMID: 21031596, 26387595, 31831025). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with PEX1-related conditions. ClinVar contains an entry for this variant (Variation ID: 287046). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV003475913 | SCV004203385 | likely pathogenic | Heimler syndrome 1 | 2024-03-27 | criteria provided, single submitter | clinical testing |